Rabever 20 mg Tab.

• Duodenal ulcer
• Benign gastric ulcer
• Duodenal ulcer and benign gastric ulcer associated with H. pylori infection
• Healing of erosive or ulcerative Gastroesophageal Reflux Disease (GERD)
• Treatment of symptomatic GERD
• Maintenance of healing of erosive or ulcerative GERD
• Prevention or treatment of NSAID-induced ulcers
• Zollinger-Ellison Syndrome

for maintaining healing and reduction in relapse rates of heartburn symptoms in patients with erosive or ulcerative GERD maintenance. Controlled studies do not extend beyond 12 months.

Prevention or treatment of NSAID-induced ulcers: Rabeprazole 20 mg once daily, in patients receiving treatment with NSAIDs.

Zollinger-Ellison Syndrome: The recommended adult oral starting dose is 60 mg once a day. Doses should be adjusted to individual patient needs and should continue for as long as clinically indicated. Some patients may require divided doses. Doses up to 100 mg once daily and 60 mg twice daily have been administered Duodenal ulcer: Rabeprazole 20 mg in the morning is indicated for 4 weeks treatment in the healing and symptomatic relief of duodenal ulcer. Most patients heal within 4 weeks.

Benign gastric ulcer: 20 mg daily in the morning for 6 weeks, followed by a further 6 weeks if not fully cured. Duodenal ulcer and benign gastric ulcer associated with H. pylori infection: Rabeprazole in combination with Amoxicillin and Clarithromycin as a three drug regimen is indicated for the treatment of patients with H. pylori infection and duodenal ulcer disease. Rabeprazole offers a faster therapy option than other PPIs, up to 10 to 14 days 20 mg once daily.

Healing of erosive or ulcerative Gastroesophageal Reflux Disease (GERD): 20 mg daily in the morning 4 to 8 weeks. Those patients who have not healed after 8 weeks of treatment, an additional 8-week course of Rabeprazole may be considered.

Treatment of symptomatic GERD: The recommended adult oral dose of Rabeprazole is 20 mg once daily for 4 weeks. If symptoms do not resolve completely after 4 weeks, an additional course of treatment may be considered.

Maintenance of healing of erosive or ulcerative GERD: Rabeprazole is indicated.

Treatment of GERD in Pediatric Patients 1 to 11 Years of Age: The recommended dosage for pediatric patients 1 to 11 years of age by body weight is:

• Less than 15 kg: 5 mg once daily for up to 12 weeks with the option to increase to 10 mg if inadequate response.
• 15 kg or more: 10 mg once daily for up to 12 weeks.